Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
Clinical trial NCT01143662 · COMPLETED
Trial details
- NCT number
- NCT01143662
- Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-04-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.